AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20183737 — intervention group
Group type: EXPERIMENTAL
Intervention: High hypnotizability
Number of subjects: 124
Study 20183737 — intervention group
Group type: COMPARATOR
Intervention: IES total
Number of subjects: 124
Study 18844799 — intervention group
Group type: EXPERIMENTAL
Intervention: City nurse intervention on three acute wards
Number of subjects: 3
Study 18844799 — intervention group
Group type: COMPARATOR
Intervention: Control wards (five wards)
Number of subjects: 3
Study 11535321 — intervention group
Group type: EXPERIMENTAL
Intervention: Twinrix (720 EL.U inactivated hepatitis A antigen and 20 mcg recombinant hepatitis B surface antigen per milliliter) on a 0, 1, 6 month schedule
Number of subjects: 773
Study 11535321 — intervention group
Group type: COMPARATOR
Intervention: Havrix (1440 EL.U/ml of hepatitis A antigen at 0, 6 months) and Engerix-B (20 mcg of hepatitis B surface antigen at 0, 1, 6 months)
Number of subjects: 773
Study 9466161 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran 200 mg/day
Number of subjects: 0
Study 9466161 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine 150 mg/day
Number of subjects: 0
Study 7948450 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma KYN concentration in patients with endogenous anxiety
Number of subjects: 30
Study 7948450 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma KYN concentration in patients with endogenous depression
Number of subjects: 30
Study 7948450 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment plasma KYN concentration
Number of subjects: 30
Study 7948450 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma KYN concentration with severity of anxiety
Number of subjects: 30
Study 7948450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone Suppression Test (DST) and Diazepam Test (DT)
Number of subjects: 30
Study 2467447 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive laser therapy (He‐Ne laser irradiation)
Number of subjects: 0
Study 30298380 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai traditional dance group (TTDG)
Number of subjects: 43
Study 30298380 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 43
Study 28992829 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBT-I)
Number of subjects: 62
Study 28992829 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring and attention control (SMAC)
Number of subjects: 62
Study 23837530 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month graft healing period
Number of subjects: 24
Study 23837530 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month graft healing period
Number of subjects: 24
Study 23837530 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-month graft healing period
Number of subjects: 24
Study 23072263 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (15 mg/day for 5 days)
Number of subjects: 16
Study 23072263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 21548927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with PEEP at 12 cmH(2)O with recruitment maneuvers (lung-protective strategy)
Number of subjects: 900
Study 21548927 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation with PEEP at maximum 2 cmH(2)O without recruitment maneuvers (conventional strategy)
Number of subjects: 900
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized distribution sequence producing
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded method
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion criteria
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion criteria
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant flow
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' compliance
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Concrete P value
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 46
Study 18822904 — intervention group
Group type: EXPERIMENTAL
Intervention: Limitations discussion
Number of subjects: 46
Study 17147039 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular electrical stimulation (group 1)
Number of subjects: 28
Study 17147039 — intervention group
Group type: EXPERIMENTAL
Intervention: Oculomotor rehabilitation (group 2)
Number of subjects: 28
Study 12911359 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable metal laryngoscope blade
Number of subjects: 60
Study 12911359 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic disposable laryngoscope blades
Number of subjects: 60
Study 12911359 — intervention group
Group type: COMPARATOR
Intervention: Reusable Macintosh 3 laryngoscope blade
Number of subjects: 60
Study 10853616 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 19
Study 10853616 — intervention group
Group type: EXPERIMENTAL
Intervention: S,R-labetalol
Number of subjects: 19
Study 10853616 — intervention group
Group type: EXPERIMENTAL
Intervention: S,S-labetalol
Number of subjects: 19
Study 10853616 — intervention group
Group type: EXPERIMENTAL
Intervention: R,S-labetalol
Number of subjects: 19
Study 10853616 — intervention group
Group type: EXPERIMENTAL
Intervention: R,R-labetalol
Number of subjects: 19
Study 9272336 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-component acellular vaccine
Number of subjects: 0
Study 9272336 — intervention group
Group type: COMPARATOR
Intervention: Whole-cell vaccine
Number of subjects: 0
Study 8096676 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acebutolol, 25 mg (acute therapy)
Number of subjects: 2
Study 8096676 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic therapy with acebutolol, 200 mg twice daily
Number of subjects: 2
Study 8096676 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers (general use)
Number of subjects: 2
Study 8096676 — intervention group
Group type: EXPERIMENTAL
Intervention: Carefully titrated doses of beta blockers with afterload-reducing agents
Number of subjects: 2
Study 31777203 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 400 mg/day
Number of subjects: 54
Study 31777203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 31777203 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 54
Study 29542344 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 4 mg medroxyprogesterone acetate (MPA), days 19-30
Number of subjects: 96
Study 29542344 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 100 mg micronized progesterone (MP), days 19-30
Number of subjects: 96
Study 29542344 — intervention group
Group type: COMPARATOR
Intervention: 100 mg C. foetida extract daily
Number of subjects: 96
Study 27476362 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured composite resin (178 brackets)
Number of subjects: 22
Study 27476362 — intervention group
Group type: COMPARATOR
Intervention: Chemical-cured composite resin (178 brackets)
Number of subjects: 22
Study 27476362 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall failure rate of brackets with both bonding systems
Number of subjects: 22
Study 27476362 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior teeth
Number of subjects: 22
Study 27476362 — intervention group
Group type: EXPERIMENTAL
Intervention: Second premolars
Number of subjects: 22
Study 25675856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat soup preload (0.8 kcal/g; 55% calories from fat)
Number of subjects: 75
Study 25675856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat soup preload
Number of subjects: 75
Study 25675856 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 75
Study 23134193 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate (666 mg, 3 times daily, total 1,998 mg/d)
Number of subjects: 100
Study 23134193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23134193 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate and Placebo (both groups)
Number of subjects: 100
Study 20654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB) with dietary counseling (100-300 calories restriction), 3 times/week, 40 min/session for 12 months
Number of subjects: 203
Study 20654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB) with dietary counseling (100-300 calories restriction)
Number of subjects: 203
Study 20654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB)
Number of subjects: 203
Study 20654643 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with dietary counseling (100-300 calories restriction)
Number of subjects: 203
Study 20654643 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 203
Study 18155874 — intervention group
Group type: EXPERIMENTAL
Intervention: Vectra Vascular Access Graft
Number of subjects: 117
Study 18155874 — intervention group
Group type: COMPARATOR
Intervention: Transposed Brachial-Basilic Fistula (TBB)
Number of subjects: 117
Study 18155874 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of arterial anastomosis stenosis treated with angioplasty
Number of subjects: 117
Study 18155874 — intervention group
Group type: EXPERIMENTAL
Intervention: Vectra grafts with any intra-graft, venous outflow, draining or central vein stenosis treated with angioplasty
Number of subjects: 117
Study 16495014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 4 sessions
Number of subjects: 158
Study 16495014 — intervention group
Group type: COMPARATOR
Intervention: Education/attention control condition
Number of subjects: 158
Study 12490769 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8‐10 mg/day)
Number of subjects: 74
Study 12490769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 12490769 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine (20‐40 mg/day)
Number of subjects: 74
Study 10929902 — intervention group
Group type: EXPERIMENTAL
Intervention: Constipated patients with slow colonic transit
Number of subjects: 50
Study 10929902 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study 9352392 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 10‐6734 (80 mg)
Number of subjects: 24
Study 9352392 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 10‐6734 (300 mg)
Number of subjects: 24
Study 9352392 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 10‐6734
Number of subjects: 24
Study 9352392 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 10‐6735 (active metabolite)
Number of subjects: 24
Study 8245114 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice group (three 10‐minute practice sessions 1 day to 1 week before measurement)
Number of subjects: 27
Study 8245114 — intervention group
Group type: EXPERIMENTAL
Intervention: Acclimation group (5 minutes acclimation to mouthpiece and noseclip before measurement)
Number of subjects: 27
Study 8245114 — intervention group
Group type: COMPARATOR
Intervention: Control group (no practice)
Number of subjects: 27
Study 2952029 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct threading method of radial artery cannulation
Number of subjects: 200
Study 2952029 — intervention group
Group type: COMPARATOR
Intervention: Transfixion method of radial artery cannulation
Number of subjects: 200
Study 31492113 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-AssistDem intervention group
Number of subjects: 240
Study 30035585 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief strategic therapy (BST)
Number of subjects: 60
Study 30035585 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 60
Study 30035585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both BST and CBT
Number of subjects: 60
Study 26471087 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray
Number of subjects: 120
Study 26471087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25407431 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise program including supervised group sessions, serious games approach, and specific training for severely impaired persons.
Number of subjects: 0
Study 25407431 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence training for staff members focusing on PA motivation and facilitation.
Number of subjects: 0
Study 25407431 — intervention group
Group type: COMPARATOR
Intervention: Pre-, post-, and 3-month follow-up assessments in the intervention setting.
Number of subjects: 0
Study 25407431 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes include cognitive performance and depression of residents.
Number of subjects: 0
Study 22411302 — intervention group
Group type: EXPERIMENTAL
Intervention: In-clinic advocate intervention
Number of subjects: 0
Study 22411302 — intervention group
Group type: COMPARATOR
Intervention: Usual care (business card referral only)
Number of subjects: 0
Study 20634696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive orthoptic therapy
Number of subjects: 0
Study 20634696 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil push-ups
Number of subjects: 0
Study 20634696 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-in prism glasses
Number of subjects: 0
Study 18036454 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation (OAC)
Number of subjects: 6706
Study 18036454 — intervention group
Group type: COMPARATOR
Intervention: Combined antiplatelet therapy (aspirin plus clopidogrel)
Number of subjects: 6706
Study 18036454 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxysmal AF
Number of subjects: 6706
Study 18036454 — intervention group
Group type: COMPARATOR
Intervention: Sustained AF
Number of subjects: 6706
Study 18036454 — intervention group
Group type: EXPERIMENTAL
Intervention: OAC
Number of subjects: 6706
Study 16169316 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMI STEMI score
Number of subjects: 47882
Study 16169316 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 47882
Study 16169316 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort mortality rates
Number of subjects: 47882
Study 12702735 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml of a 6.4 % carbohydrate beverage (GLU trial)
Number of subjects: 7
Study 12702735 — intervention group
Group type: COMPARATOR
Intervention: Sweet placebo beverage (CON trial)
Number of subjects: 7
Study 10680106 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% glucose solution (Group G)
Number of subjects: 20
Study 10680106 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution (Group R)
Number of subjects: 20
Study 8708587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive advice (group sessions led by a health care professional)
Number of subjects: 384
Study 8708587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological treatment (pravastatin)
Number of subjects: 384
Study 8708587 — intervention group
Group type: COMPARATOR
Intervention: Usual advice
Number of subjects: 384
Study 8708587 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 384
Study 1660502 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with additional fluid (600 mL)
Number of subjects: 11
Study 1660502 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran without additional fluid
Number of subjects: 11
Study 6895918 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin indanyl sodium (2 tablets, 4 times daily, 24 hours before and after biopsy)
Number of subjects: 63
Study 6895918 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 tablets, 4 times daily, 24 hours before and after biopsy)
Number of subjects: 63
Study 6895918 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin indanyl sodium
Number of subjects: 63
Study 6895918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30836804 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored 1-month (8-session) intervention
Number of subjects: 233
Study 30836804 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 233
Study 28515057 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy alone
Number of subjects: 118
Study 28515057 — intervention group
Group type: COMPARATOR
Intervention: Early reconstruction plus exercise therapy
Number of subjects: 118
Study 28515057 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed reconstruction
Number of subjects: 118
Study 27086041 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly oral doses of 60,000 IU of cholecalciferol
Number of subjects: 21315
Study 27086041 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 21315
Study 24485000 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB in conjunction with omentectomy
Number of subjects: 81
Study 24485000 — intervention group
Group type: COMPARATOR
Intervention: RYGB alone
Number of subjects: 81
Study 21946392 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg daily)
Number of subjects: 0
Study 21946392 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (40 mg daily)
Number of subjects: 0
Study 21946392 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Aliskiren + Olmesartan)
Number of subjects: 0
Study 18603228 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management skills to reduce drooling
Number of subjects: 10
Study 17721009 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipophilic statins (atorvastatin, fluvastatin, pitavastatin, simvastatin)
Number of subjects: 241
Study 17721009 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic statins (pravastatin)
Number of subjects: 241
Study 16135917 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide excision (WE) plus lymphatic mapping/sentinel node biopsy (LM/SNB) with immediate complete lymphadenectomy (CLND) for sentinel node (SN) metastases
Number of subjects: 2001
Study 16135917 — intervention group
Group type: COMPARATOR
Intervention: Wide excision (WE) plus observation (WEO) with delayed CLND for nodal recurrence
Number of subjects: 2001
Study 12186986 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 101
Study 12186986 — intervention group
Group type: COMPARATOR
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 101
Study 10423466 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation and abciximab
Number of subjects: 2399
Study 10423466 — intervention group
Group type: COMPARATOR
Intervention: Stent implantation and placebo
Number of subjects: 2399
Study 10423466 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon angioplasty and abciximab
Number of subjects: 2399
Study 10423466 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus abciximab vs Angioplasty plus abciximab
Number of subjects: 2399
Study 10423466 — intervention group
Group type: COMPARATOR
Intervention: Stenting and placebo
Number of subjects: 2399
Study 10423466 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty and abciximab
Number of subjects: 2399
Study 7741168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacitracin zinc (120,000 U, 10-day treatment)
Number of subjects: 102
Study 7741168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacitracin (120,000 U, 10-day treatment)
Number of subjects: 102
Study 7741168 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin (120,000 U, 10-day treatment)
Number of subjects: 102
Study 7741168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacitracin zinc plus Neomycin (60,000 U each, 10-day treatment)
Number of subjects: 102
Study 7741168 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin zinc
Number of subjects: 102
Study 7741168 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin
Number of subjects: 102
Study 7741168 — intervention group
Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 102
Study 7741168 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin zinc plus Neomycin
Number of subjects: 102
Study 2184003 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 0
Study 7260183 — intervention group
Group type: EXPERIMENTAL
Intervention: Success group (received false feedback and instructions that conveyed successful control)
Number of subjects: 48
Study 7260183 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure group (received feedback and instructions that conveyed outcomes had not been controlled)
Number of subjects: 48
Study 7260183 — intervention group
Group type: COMPARATOR
Intervention: Control group (given no specific task)
Number of subjects: 48
Study 7260183 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups during test stage (asked to reduce frontal muscle tension levels through relaxation with true EMG feedback)
Number of subjects: 48
Study 31581815 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard analysis methods applied to data from a biomarker-stratified outcome-adaptive randomization trial
Number of subjects: 0
Study 31581815 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed adjusted estimators
Number of subjects: 0
Study 28733805 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 24 U
Number of subjects: 300
Study 28733805 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 12 U
Number of subjects: 300
Study 28733805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 26473191 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted anticancer agents in Phase III RCTs
Number of subjects: 0
Study 26473191 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 23337270 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle block administered after inflation of tourniquet (Group A)
Number of subjects: 60
Study 23337270 — intervention group
Group type: COMPARATOR
Intervention: Ankle block administered before inflation of tourniquet (Group B)
Number of subjects: 60